Anti-Müllerian hormone and polycystic ovary syndrome

详细信息    查看全文

• 作者：Priya Bhide ; MD ; MRCOG ^{priya.bhide@homerton.nhs.uk} ; Roy Homburg ; FRCOG ; ^{royhomburg@gmail.com}
• 关键词：Anti-Mü ; llerian hormone ; polycystic ovary syndrome
• 刊名：Best Practice & Research Clinical Obstetrics & Gynaecology
• 出版年：2016
• 出版时间：November 2016
• 年：2016
• 卷：37
• 期：Complete
• 页码：38-45
• 全文大小：299 K
• 卷排序：37

文摘

The Anti-Müllerian hormone (AMH) levels are significantly higher in polycystic ovary syndrome (PCOS) than non-PCOS women. The increased AMH levels are due to the higher number of follicle cells and per-follicle AMH production. The AMH is postulated to play a key role in anovulation in PCOS. The AMH is currently not included as a diagnostic criterion for PCOS. The AMH is useful for the prediction of high ovarian response during in vitro fertilisation (IVF).